174 related articles for article (PubMed ID: 17174213)
1. [Thrombosis of a cardiopulmonary bypass circuit despite recommended hypocoagulation with danaparoid during the acute phase of type II heparin-induced thrombocytopenia].
Salmi L; Elalamy I; Leroy-Matheron C; Houel R; Thébert D; Duvaldestin P
Ann Fr Anesth Reanim; 2006; 25(11-12):1144-8. PubMed ID: 17174213
[TBL] [Abstract][Full Text] [Related]
2. Heparin-induced thrombocytopenia type II: perioperative management using danaparoid in a coronary artery bypass patient with renal failure.
Westphal K; Martens S; Strouhal U; Matheis G; Lindhoff-Last E; Wimmer-Greinecker G; Lischke V
Thorac Cardiovasc Surg; 1997 Dec; 45(6):318-20. PubMed ID: 9477469
[TBL] [Abstract][Full Text] [Related]
3. Cardiopulmonary bypass and heparin-induced thrombocytopenia: pitfalls of anticoagulation with danaparoid.
Kanagasabay R; Unsworth-White MJ; Farnsworth G; Haxby EJ; Smith EE
J Thorac Cardiovasc Surg; 2000 Aug; 120(2):428-9. PubMed ID: 10917979
[No Abstract] [Full Text] [Related]
4. Use of danaparoid during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia.
Olin DA; Urdaneta F; Lobato EB
J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):707-9. PubMed ID: 11139115
[No Abstract] [Full Text] [Related]
5. Pediatric heparin-induced thrombocytopenia: management with Danaparoid (orgaran).
Saxon BR; Black MD; Edgell D; Noel D; Leaker MT
Ann Thorac Surg; 1999 Sep; 68(3):1076-8. PubMed ID: 10510017
[TBL] [Abstract][Full Text] [Related]
6. Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass.
von Segesser LK; Mueller X; Marty B; Horisberger J; Corno A
Perfusion; 2001 Sep; 16(5):411-6. PubMed ID: 11565896
[TBL] [Abstract][Full Text] [Related]
7. Failure of danaparoid anticoagulation for cardiopulmonary bypass.
Ariano RE; Bhattacharya SK; Moon M; Brownell LG
J Thorac Cardiovasc Surg; 2000 Jan; 119(1):167-8. PubMed ID: 10612777
[No Abstract] [Full Text] [Related]
8. [Cardiac surgery in patients with heparin-induced thrombocytopenia (HIT II)].
Jović MD; Nezić DG; Calija BM; Nenadić DS; Knezević AM; Borzanović MD; Krivokapić BM; Petrović IM; Djukanović BP
Acta Chir Iugosl; 2009; 56(1):47-52. PubMed ID: 19504989
[TBL] [Abstract][Full Text] [Related]
9. Coronary artery bypass grafting in a patient with type II heparin associated thrombopenia.
Christiansen S; Geiger A; Splittgerber FH; Reidemeister JC
Cardiovasc Surg; 1998 Feb; 6(1):90-3. PubMed ID: 9546852
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal membrane oxygenation with danaparoid sodium after massive pulmonary embolism.
Bauer C; Vichova Z; Ffrench P; Hercule C; Jegaden O; Bastien O; Lehot JJ
Anesth Analg; 2008 Apr; 106(4):1101-3, table of contents. PubMed ID: 18349178
[TBL] [Abstract][Full Text] [Related]
11. [Extracorporeal circulation with danaparoid sodium for valve replacement in thrombocytopenia induced by type II heparin].
Salmi L; Leroy-Matheron C; LeBesnerais P; Rosanval O; Duvaldestin P; Gouault-Heilmann M
Ann Fr Anesth Reanim; 2001 Nov; 20(9):799-802. PubMed ID: 11759322
[TBL] [Abstract][Full Text] [Related]
12. [Peri-operative anticoagulation with danaparoid for a patient with Budd-Chiari syndrome and heparin-induced thrombocytopenia].
Brémaud M; De Maistre E; Junke E; Guerci A; Lalot JM; Longrois D; Lecompte T; Meistelman C
Ann Fr Anesth Reanim; 2004 Feb; 23(1):50-5. PubMed ID: 14980323
[TBL] [Abstract][Full Text] [Related]
13. Danaparoid sodium (Orgaran) in four children with heparin-induced thrombocytopenia type II.
Zöhrer' B; Zenz W; Rettenbacher A; Covi P; Kurnik K; Kroll H; Grubbauer HM; Muntean W
Acta Paediatr; 2001 Jul; 90(7):765-71. PubMed ID: 11519979
[TBL] [Abstract][Full Text] [Related]
14. Danaparoid for cardiopulmonary bypass in patients with previous heparin-induced thrombocytopenia.
Gillis S; Merin G; Zahger D; Deeb M; Drenger B; Hyam E; Eldor A
Br J Haematol; 1997 Sep; 98(3):657-9. PubMed ID: 9332322
[TBL] [Abstract][Full Text] [Related]
15. [Danaparoid in pregnancy in cases of heparin intolerance - use in 59 cases].
Schindewolf M; Magnani HN; Lindhoff-Last E
Hamostaseologie; 2007 May; 27(2):89-97. PubMed ID: 17479171
[TBL] [Abstract][Full Text] [Related]
16. Drugs for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopenia.
Lubenow N; Greinacher A
Am J Cardiovasc Drugs; 2001; 1(6):429-43. PubMed ID: 14728002
[TBL] [Abstract][Full Text] [Related]
17. Danaparoid use for haemodialysis in a morbidly obese patient with heparin-induced thrombocytopenia - Need for a higher than recommended weight-based dosing.
Castelino RL; Maddula M; Tarafdar S; Sud K; Kairaitis L
Thromb Res; 2019 Aug; 180():70-73. PubMed ID: 31229923
[TBL] [Abstract][Full Text] [Related]
18. [Successful lysis of iliofemoral and inferior vena cava thrombi in heparin-induced type-II thrombocytopenia].
Emig U; Meyer T; Buchwald AB
Dtsch Med Wochenschr; 1997 Aug; 122(31-32):965-8. PubMed ID: 9280716
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulative management of patients requiring left ventricular assist device implantation and suffering from heparin-induced thrombocytopenia type II.
Christiansen S; Jahn UR; Meyer J; Scheld HH; Van Aken H; Kehrel BE; Hammel D
Ann Thorac Surg; 2000 Mar; 69(3):774-7. PubMed ID: 10750760
[TBL] [Abstract][Full Text] [Related]
20. [Use of Organon, a synthetic heparinoid, in two cardiopulmonary bypass procedures in the same patient sensitive to heparin].
Pineau E; Le Bret E; Folliguet T; Saint Maurice OS; Carbognani D; Laborde F
Arch Mal Coeur Vaiss; 2001 Feb; 94(2):144-7. PubMed ID: 11265553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]